Menu

Blog

Archive for the ‘biotech/medical’ category: Page 335

Dec 28, 2023

Elon Musk slams media for linking robot attack to Optimus

Posted by in categories: biotech/medical, Elon Musk, robotics/AI

Industrial mishaps are not rare but caution is prime. Tesla’s CEO Elon Musk has lashed out at the media for sensationalizing an old injury caused by a robot at his Giga Texas factory in Austin, Texas. He claimed that the media was trying to link the incident to his futuristic Optimus robots, which he said would usher in a new era of abundance.

The incident, which happened two years ago, involved a software engineer who was programming software for robots that cut car parts from freshly cast aluminum. While he was working, he was unaware that one of the robots was still active while the other two were disabled for maintenance. The active robot then attacked the engineer, pinning him down and clawing at his back and arm. The attack left a trail of blood on the factory floor, as well as an open wound on the engineer’s left hand.

Dec 28, 2023

This E-tongue mimicks human taste and recommends wine with different foods

Posted by in categories: biotech/medical, robotics/AI

Scientists pave the way for new culinary frontiers.


This E-tongue can identify four tastes – saltiness, sourness, astringency, and sweetness – in just a tiny bit of food, and uses deep-learning technology to understand taste. It even works well with different kinds of wines.

The E-tongue is like a super tool that can be used in different industries like food, drinks, makeup, and medicine, explained the researchers in a press release by Daegu Gyeongbuk Institute of Science & Technology (DGIST).

Continue reading “This E-tongue mimicks human taste and recommends wine with different foods” »

Dec 28, 2023

One CAR T-Cell Therapy for Blood Cancers?

Posted by in category: biotech/medical

In the Lord of the Rings, there was “one ring to rule them all.” Now, a team of researchers is developing their own single ruler, an approach to CAR T-cell therapy that could treat all forms and types of blood cancer.

In experiments in mouse models of different blood cancers, the treatment rapidly eliminated tumors, including in mice with acute myeloid leukemia (AML), a difficult-to-treat type of blood cancer for which researchers have struggled to develop effective immunotherapies.

There was also no evidence of serious side effects in the animals. And, finally—and distinctly from the standard approach to current CAR T-cell therapies—it provided the mice with a healthy supply of new blood cells.

Dec 28, 2023

This Mind-Reading Cap Can Translate Thoughts to Text Thanks to AI

Posted by in categories: biotech/medical, robotics/AI

Previously, researchers have used implants surgically placed in the brain or bulky, expensive machines to translate brain activity into text. The new approach, presented at this week’s NeurIPS conference by researchers from the University of Technology Sydney, is impressive for its use of a non-invasive EEG cap and the potential to generalize beyond one or two people.

The team built an AI model called DeWave that’s trained on brain activity and language and linked it up to a large language model—the technology behind ChatGPT—to help convert brain activity into words. In a preprint posted on arXiv, the model beat previous top marks for EEG thought-to-text translation with an accuracy of roughly 40 percent. Chin-Teng Lin, corresponding author on the paper, told MSN they’ve more recently upped the accuracy to 60 percent. The results are still being peer-reviewed.

Continue reading “This Mind-Reading Cap Can Translate Thoughts to Text Thanks to AI” »

Dec 28, 2023

CRISPR Gene Editing Had a Breakthrough Year—and It’s Only Getting Started

Posted by in categories: bioengineering, biotech/medical

CRISPR had a huge year. Even better, it’s still a work in progress, with the potential to reshape biotechnology for decades to come.

Dec 28, 2023

Intermittent Fasting Seems to Result in Dynamic Changes to The Human Brain

Posted by in categories: biotech/medical, food, neuroscience

Scientists looking to tackle our ongoing obesity crisis have made an important discovery: Intermittent fasting leads to significant changes both in the gut and the brain, which may open up new options for maintaining a healthy weight.

Researchers from China studied 25 volunteers classed as obese over a period of 62 days, during which they took part in an intermittent energy restriction (IER) program – a regime that involves careful control of calorie intake and fasting on some days.

Not only did the participants in the study lose weight – 7.6 kilograms (16.8 pounds) or 7.8 percent of their body weight on average – there was also evidence of shifts in the activity of obesity-related regions of the brain, and in the make-up of gut bacteria.

Dec 27, 2023

Probing when dCas9 tolerates DNA mismatches

Posted by in category: biotech/medical

Sensing changes in ionic current as barcoded DNA translocates through solid-state nanopores allows the study of how nucleotide sequences alter the DNA-binding specificity of the catalytically inactive Cas9 ribonucleoprotein complex.

Dec 27, 2023

Why ‘resurrection biology’ is gaining traction around the world

Posted by in categories: bioengineering, biotech/medical, existential risks, genetics

Resurrection biology — attempting to bring strings of molecules and more complex organisms back to life — is gaining traction in labs around the world.

The work is a far cry from the genetically engineered dinosaurs that escape in the blockbuster movie “Jurassic Park,” although for some scientists the ultimate goal is de-extinction and resurrecting animals and plants that have been lost.

Other researchers are looking to the past for new sources of drugs or to sound an alarm about the possibility of long-dormant pathogens. The field of study is also about recreating elements of human history in an attempt to better understand how our ancestors might have lived and died.

Dec 27, 2023

New Genomics Databases Could Drive Major Breakthroughs

Posted by in categories: biotech/medical, genetics

The projects are poised to offer unprecedented insights into human genetic diversity and improve treatment of disease.

Dec 27, 2023

NIH study shows elevating NAD+ with NR supplementation effectively reduces inflammation

Posted by in categories: biotech/medical, life extension, neuroscience

Persistent chronic inflammation – also recognized as metaflammation or inflammaging – emerges as a consistent factor in ailing populations, in conditions correlated with age-related deterioration and even in ostensibly robust individuals. This phenomenon has been correlated with the onset of autoimmune disorders such as psoriasis and lupus, as well as chronic diseases including diabetes, cardiovascular disease, Alzheimer’s and Parkinson’s, among others. Investigations have substantiated that environmental and lifestyle variables such as smoking, a poor diet, physical inactivity and lack of or poor quality sleep can contribute to the perpetuation of chronic underlying inflammation.

Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme; vital for the functionality of all living cells, the preservation of intracellular NAD+ pools plays a crucial role in supporting cellular and metabolic processes. Key among these processes is the production of cellular energy, adenosine triphosphate (ATP), and DNA repair. Research indicates that a decrease in NAD+ levels is linked to compromised inflammatory responses and innate immune dysfunction. This implies that the levels of NAD+ may play a critical role in the operational efficacy of immune cells.

NR is an efficient NAD+ precursor; clinically proven to increase NAD+ safely and effectively it has become a popular supplement, and there is a growing body of clinical evidence demonstrating the anti-inflammatory effects of NR supplementation (either alone or in combination with other ingredients) for healthy, older adults, or those with inflammation-related disorders [4]. Indeed, NR supplementation has potential for more robust effects among the elderly and diseased populations as they tend to have compromised NAD+ and a higher inflammatory status.

Page 335 of 2,739First332333334335336337338339Last